Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Antibody Drug Conjugate market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Antibody Drug Conjugatemarket, defines the market attractiveness level of Antibody Drug Conjugate market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Antibody Drug Conjugate industry, describes the types of Antibody Drug Conjugate market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antibody Drug Conjugate market and the development prospects and opportunities of Antibody Drug Conjugate industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antibody Drug Conjugate market in Chapter 13.
By Player:
Immunomedics
Celldex Therapeutics
ImmunoGen
Mersana Therapeutics
Oxford BioTherapeutics
Takeda Pharmaceutical Company Limited
Seattle Genetics/Takeda
Millennium Pharmaceuticals
Heidelberg Pharma
Bayer HealthCare
Pfizer
Roche
By Type:
Adcetris
Kadcyl
Other
By End-User:
Hospital
Pharmaceutical Company
Research Institutions
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Antibody Drug Conjugate Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Antibody Drug Conjugate Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Antibody Drug Conjugate Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Antibody Drug Conjugate Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Antibody Drug Conjugate Market Analysis and Outlook to 2022
-
7.1 Global Antibody Drug Conjugate Consumption (2017-2022)
-
7.2 United States Antibody Drug Conjugate Consumption (2017-2022)
-
7.3 Europe Antibody Drug Conjugate Consumption (2017-2022)
-
7.4 China Antibody Drug Conjugate Consumption (2017-2022)
-
7.5 Japan Antibody Drug Conjugate Consumption (2017-2022)
-
7.6 India Antibody Drug Conjugate Consumption (2017-2022)
-
7.7 South Korea Antibody Drug Conjugate Consumption (2017-2022)
8 Region and Country-wise Antibody Drug Conjugate Market Analysis and Outlook to 2028
-
8.1 Global Antibody Drug Conjugate Consumption Forecast (2022-2028)
-
8.2 United States Antibody Drug Conjugate Consumption Forecast (2022-2028)
-
8.3 Europe Antibody Drug Conjugate Consumption Forecast (2022-2028)
-
8.4 China Antibody Drug Conjugate Consumption Forecast (2022-2028)
-
8.5 Japan Antibody Drug Conjugate Consumption Forecast (2022-2028)
-
8.6 India Antibody Drug Conjugate Consumption Forecast (2022-2028)
-
8.7 South Korea Antibody Drug Conjugate Consumption Forecast (2022-2028)
9 Global Antibody Drug Conjugate Market Outlook by Types and Applications to 2022
-
9.1 Global Antibody Drug Conjugate Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Adcetris Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Kadcyl Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Antibody Drug Conjugate Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmaceutical Company Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Institutions Consumption and Growth Rate (2017-2022)
10 Global Antibody Drug Conjugate Market Outlook by Types and Applications to 2028
-
10.1 Global Antibody Drug Conjugate Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Adcetris Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Kadcyl Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Antibody Drug Conjugate Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pharmaceutical Company Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Institutions Consumption Forecast and Growth Rate (2022-2028)
11 Global Antibody Drug Conjugate Import and Export Analysis (Top 5 Countries)
-
11.1 Global Antibody Drug Conjugate Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Antibody Drug Conjugate Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Antibody Drug Conjugate Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Antibody Drug Conjugate Market Competitive Analysis
-
14.1 Immunomedics
-
14.1.1 Immunomedics Company Details
-
14.1.2 Immunomedics Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Immunomedics Antibody Drug Conjugate Product and Service
-
14.2 Celldex Therapeutics
-
14.2.1 Celldex Therapeutics Company Details
-
14.2.2 Celldex Therapeutics Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Celldex Therapeutics Antibody Drug Conjugate Product and Service
-
14.3 ImmunoGen
-
14.3.1 ImmunoGen Company Details
-
14.3.2 ImmunoGen Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 ImmunoGen Antibody Drug Conjugate Product and Service
-
14.4 Mersana Therapeutics
-
14.4.1 Mersana Therapeutics Company Details
-
14.4.2 Mersana Therapeutics Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Mersana Therapeutics Antibody Drug Conjugate Product and Service
-
14.5 Oxford BioTherapeutics
-
14.5.1 Oxford BioTherapeutics Company Details
-
14.5.2 Oxford BioTherapeutics Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Oxford BioTherapeutics Antibody Drug Conjugate Product and Service
-
14.6 Takeda Pharmaceutical Company Limited
-
14.6.1 Takeda Pharmaceutical Company Limited Company Details
-
14.6.2 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product and Service
-
14.7 Seattle Genetics/Takeda
-
14.7.1 Seattle Genetics/Takeda Company Details
-
14.7.2 Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Seattle Genetics/Takeda Antibody Drug Conjugate Product and Service
-
14.8 Millennium Pharmaceuticals
-
14.8.1 Millennium Pharmaceuticals Company Details
-
14.8.2 Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Millennium Pharmaceuticals Antibody Drug Conjugate Product and Service
-
14.9 Heidelberg Pharma
-
14.9.1 Heidelberg Pharma Company Details
-
14.9.2 Heidelberg Pharma Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Heidelberg Pharma Antibody Drug Conjugate Product and Service
-
14.10 Bayer HealthCare
-
14.10.1 Bayer HealthCare Company Details
-
14.10.2 Bayer HealthCare Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bayer HealthCare Antibody Drug Conjugate Product and Service
-
14.11 Pfizer
-
14.11.1 Pfizer Company Details
-
14.11.2 Pfizer Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Pfizer Antibody Drug Conjugate Product and Service
-
14.12 Roche
-
14.12.1 Roche Company Details
-
14.12.2 Roche Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Roche Antibody Drug Conjugate Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Antibody Drug Conjugate
-
Figure Antibody Drug Conjugate Picture
-
Table Global Antibody Drug Conjugate Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antibody Drug Conjugate Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antibody Drug Conjugate Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Antibody Drug Conjugate Consumption by Country (2017-2022)
-
Figure United States Antibody Drug Conjugate Consumption and Growth Rate (2017-2022)
-
Table Europe Antibody Drug Conjugate Consumption and Growth Rate (2017-2022)
-
Figure China Antibody Drug Conjugate Consumption and Growth Rate (2017-2022)
-
Figure Japan Antibody Drug Conjugate Consumption and Growth Rate (2017-2022)
-
Figure India Antibody Drug Conjugate Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antibody Drug Conjugate Consumption and Growth Rate (2017-2022)
-
Figure Global Antibody Drug Conjugate Consumption Forecast by Country (2022-2028)
-
Figure United States Antibody Drug Conjugate Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antibody Drug Conjugate Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Antibody Drug Conjugate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antibody Drug Conjugate Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antibody Drug Conjugate Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antibody Drug Conjugate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adcetris Consumption and Growth Rate (2017-2022)
-
Figure Global Kadcyl Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical Company Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institutions Consumption and Growth Rate (2017-2022)
-
Figure Global Adcetris Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kadcyl Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical Company Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institutions Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Antibody Drug Conjugate Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Antibody Drug Conjugate Export by Region (Top 5 Countries) (2017-2028)
-
Table Immunomedics (Foundation Year, Company Profile and etc.)
-
Table Immunomedics Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Immunomedics Antibody Drug Conjugate Product and Service
-
Table Celldex Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Celldex Therapeutics Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celldex Therapeutics Antibody Drug Conjugate Product and Service
-
Table ImmunoGen (Foundation Year, Company Profile and etc.)
-
Table ImmunoGen Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
Table ImmunoGen Antibody Drug Conjugate Product and Service
-
Table Mersana Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Mersana Therapeutics Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mersana Therapeutics Antibody Drug Conjugate Product and Service
-
Table Oxford BioTherapeutics (Foundation Year, Company Profile and etc.)
-
Table Oxford BioTherapeutics Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oxford BioTherapeutics Antibody Drug Conjugate Product and Service
-
Table Takeda Pharmaceutical Company Limited (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product and Service
-
Table Seattle Genetics/Takeda (Foundation Year, Company Profile and etc.)
-
Table Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics/Takeda Antibody Drug Conjugate Product and Service
-
Table Millennium Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Millennium Pharmaceuticals Antibody Drug Conjugate Product and Service
-
Table Heidelberg Pharma (Foundation Year, Company Profile and etc.)
-
Table Heidelberg Pharma Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Heidelberg Pharma Antibody Drug Conjugate Product and Service
-
Table Bayer HealthCare (Foundation Year, Company Profile and etc.)
-
Table Bayer HealthCare Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer HealthCare Antibody Drug Conjugate Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Antibody Drug Conjugate Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Antibody Drug Conjugate Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Antibody Drug Conjugate Product and Service
-
